West Pharmaceutical Services Inc. (NYSE:WST) has been downgraded to Market Perform in a report by Wells Fargo & Co. today.
- Updated: September 24, 2016
Wells Fargo & Co. has downgraded West Pharmaceutical Services Inc. (NYSE:WST) to Market Perform in a report released on 9/21/2016.
Yesterday West Pharmaceutical Services Inc. (NYSE:WST) traded -2.77% lower at $81.32. The company’s 50-day moving average is $80.94 and its 200-day moving average is $74.91. The last stock close price is up -3.15% from the 200-day moving average, compared to the S&P 500 which has decreased -0.01% over the same time. 1,167,049 shares of the stock were exchanged, up from an average trading volume of 441,678
See Chart Below
West Pharmaceutical Services Inc. has a 52 week low of $52.79 and a 52 week high of $84.33 with a P/E ratio of 52.84 The company’s market cap is currently $0.
A total of 4 equity analysts have released a research note on WST. Two equity analysts rating the company a strong buy, one equity analyst rating the company a buy, one equity analyst rating the company a hold, zero equity analysts rating the company a underperform, and finally zero equity analysts rating the company a sell with a one year target of $66.00.
More About West Pharmaceutical Services Inc. (NYSE:WST)
West Pharmaceutical Services, Inc. (West) is a manufacturer of components and systems for the packaging and delivery of injectable drugs, as well as delivery system components for the pharmaceutical, healthcare and consumer products industries. The Company's segments include Pharmaceutical Packaging Systems segment (Packaging Systems) and the Pharmaceutical Delivery Systems segment (Delivery Systems). Its Packaging Systems segment includes primary packaging components and systems for injectable drug delivery, other components used in syringe, intravenous and blood collection systems, and prefillable syringe components. Its Delivery Systems segment includes safety and administration systems, multi-component systems for drug containment and administration and various custom contract-manufacturing solutions.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.